Our previous findings demonstrating the important role of the IDO/AhR/Treg/Th17 axis in the control of pulmonary PCM led us to comparatively investigate the immunomodulatory effect of two different agonists and one antagonist of AhR signaling. This evidence concerns the gene AHR and paracoccidioidomycosis.